We are live on ! Find out more
NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.23B
1-Year Est. Return 81.32%
This Fund
S&P 500
This Quarter Est. Return
+8.83%
1 Year Est. Return
+81.32%
3 Year Est. Return
+192.63%
5 Year Est. Return
+125.03%
10 Year Est. Return
+943.65%
AUM
$681M
AUM Growth
+$277M
Cap. Flow
+$215M
Cap. Flow %
31.52%
Top 10 Hldgs %
100%
Holding
7
New
2
Increased
–
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$205M
2
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
+$14.3M

Top Sells

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$2.64M

Sector Composition

Rank Sector Weight
1 Healthcare 37.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTI icon
1
Vanguard Total Stock Market ETF
VTI
$654B
$286M 41.96%
2,979,100
– –
ISEE
2
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$223M 32.76%
+6,896,819
New +$205M
VGK icon
3
Vanguard FTSE Europe ETF
VGK
$30.1B
$124M 18.14%
2,101,000
– –
WMGI
4
DELISTED
Wright Medical Group Inc
WMGI
$18M 2.64%
585,759
– –
TTPH
5
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$16.2M 2.38%
+60,000
New +$14.3M
PTCT icon
6
PTC Therapeutics
PTCT
$6.34B
$12.8M 1.88%
597,359
-150,000
-20% -$2.64M

Similar funds

HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
GX
Greylock XIV Menlo Park, California $1.24B AUM
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
CA
Cullinan Associates Louisville, Kentucky $1.24B AUM 28.12% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Novo Holdings A/S's Q4 2013 Portfolio in Review

As of Q4 2013, Novo Holdings A/S held 7 positions worth $681M, up 69% from $404M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Novo Holdings A/S deployed $215M of net new capital in Q4 2013, opening 2 new positions. Its largest new stake was IVERIC bio, Inc. Common Stock: 6,896,819 shares worth $223M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 6.6% a quarter earlier.

On the sell side, the largest reduction was PTC Therapeutics, an estimated $2.64M trimmed.

  • Novo Holdings A/S's largest Q4 2013 buy was IVERIC bio, Inc. Common Stock: 6,896,819 shares worth $223M.
  • Novo Holdings A/S's biggest Q4 2013 reduction was PTC Therapeutics, cutting an estimated $2.64M.
  • Novo Holdings A/S's ten largest holdings make up 100% of its $681M portfolio in Q4 2013.
  • Novo Holdings A/S opened 2 new positions and closed 0 in Q4 2013.
  • Novo Holdings A/S's portfolio value rose 69% quarter-over-quarter to $681M.

Based on Novo Holdings A/S's 13F filing for Q4 2013, filed 14 Aug 2014.